Treatment outcomes and cost comparisons for older adults with T4 laryngeal squamous cell cancer.
Jessica D McDermottArya AminiElizabeth MolinaWilliam A StokesSana D KaramPublished in: Head & neck (2022)
Older patients with T4 larynx cancer had similar survival rates when treated with CR, SR, and SCR. Average total health care costs were not significantly different between modalities. Patients not eligible for triple-modality could consider these other treatment options.